Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.59) by 2.52 percent. This is a 51.2 percent increase over losses of $(1.25) per share from the same period last year. The company reported quarterly sales of $24.552 million which beat the analyst consensus estimate of $22.862 million by 7.39 percent. This is a 62.70 percent increase over sales of $15.090 million the same period last year.